Page 59 - 2018食藥署年報(英文版)

to provide prosecution and justice department real-time audition and inspection results/analysis
as the foundation for administrative procedures. Besides that, the TFDA is also keen to develop
short-acting testing methods, in order to prevent illegal drugs from being distributed and to
maintain safe drug use.

2. Successfully prevent illegal BTX preparations from being

distributed into Taiwan

Under the assistance of TFDA, MOF seized unapproved BTX preparations imported
from South Korea (Figure3-8). The test results showed that the illegal preparations contained
Botulinum Toxin Type A, indicating that the importer has violated the Pharmaceutical Affair Act
Article 22-1, Paragraph 2: Self-import medicinal products without approval. Such information

then was launched on the TFDA website to suggest to the public how to choose legal products
rather than use medicinal products without approved sources; and to help custom officers be
aware of similar incidents. In 2017, with the assistance of TFDA, MOF successfully stopped 5
batches of similar BTX preparations (either through posted packages or tourists) from entering
Taiwan and thus preventing illegal drugs from being distributed into the Taiwan market.

Figure3-8 BTX preparation samples

3. TFDA hosted the “2017 APEC Conference on Management and

Related Scientific Detection Technology for Adulteration of
Dietary Supplements with Drug and Drug Analogs”

TFDA hosted the “2017 APEC Conference on Management and Related Scientific Detection
Technology for Adulteration of Dietary Supplements with Drug and Drug Analogs” at NTUH
International Convention center between June 28-29, 2017 (Figure 3-9), more than 200 industry,
academy and official prestigious guests from the US, Europe, Japan, Singapore, South Korea and

57